We are live on ! Find out more
CCEL icon

Cryo-Cell International

15 hedge funds and large institutions have $4.97M invested in Cryo-Cell International in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more funds holding

Funds holding: 1215 (+3)

12% more capital invested

Capital invested by funds: $4.43M → $4.97M (+$545K)

0.28% more ownership

Funds ownership: 10.16%10.43% (+0.28%)

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

Holders
15
Holders Change
+3
Holders Change %
+25%
% of All Funds
0.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
4
Reduced
4
Closed
Calls
Puts
Net Calls
Net Calls Change

CCEL Hedge Fund Activity: Q4 2023 in Review

15 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Cryo-Cell International (CCEL) for Q4 2023, worth a combined $4.97M — up 12% from $4.43M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new CCEL positions and 0 closed out — a net gain of 3 holders — while 4 added to existing stakes and 4 trimmed.

The largest buyer was Northern Trust, opening a new position worth an estimated $136K. The largest seller was MassMutual Private Wealth & Trust, cutting an estimated $51.4K.

  • 15 institutional investors held Cryo-Cell International (CCEL) as of Q4 2023, up from 12 in Q3 2023.
  • Funds reported $4.97M of Cryo-Cell International stock for Q4 2023, up 12% quarter-over-quarter.
  • 3 funds opened new Cryo-Cell International positions in Q4 2023 and 0 closed out, a net change of +3 holders.
  • The largest Cryo-Cell International buyer in Q4 2023 was Northern Trust, an estimated $136K added.
  • The largest Cryo-Cell International seller in Q4 2023 was MassMutual Private Wealth & Trust, an estimated $51.4K sold.

Based on aggregated 13F filings for Q4 2023.